Moreover, ex vivo bioluminescence analysis showed a significant decrease in tumor signals in the lungs of gMSI2 CAF group, indicating that MSI2-deficient CAFs inhibited NSCLC lung metastasis (Fig. 3E). Here, MSI2 is linked to non-small cell lung carcinoma.